ERBB2 and neoplasm: In this system, a score of IHC1+ signifies no significant HER2 expression; IHC2+ is considered equivocal and may require further testing, while IHC3+ confirms strong HER2 positivity, indicating that the tumor may respond well to therapies targeting the HER2 protein.